KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Long-Term Investments (2020 - 2025)

Clover Health Investments' Long-Term Investments history spans 6 years, with the latest figure at $187.1 million for Q4 2025.

  • For Q4 2025, Long-Term Investments fell 7.25% year-over-year to $187.1 million; the TTM value through Dec 2025 reached $187.1 million, down 7.25%, while the annual FY2025 figure was $187.1 million, 7.25% down from the prior year.
  • Long-Term Investments reached $187.1 million in Q4 2025 per CLOV's latest filing, up from $180.7 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $337.0 million in Q4 2022 to a low of $335000.0 in Q4 2021.
  • Average Long-Term Investments over 5 years is $108.4 million, with a median of $71.8 million recorded in 2021.
  • Peak YoY movement for Long-Term Investments: surged 100496.12% in 2022, then crashed 99.41% in 2024.
  • A 5-year view of Long-Term Investments shows it stood at $335000.0 in 2021, then soared by 100496.12% to $337.0 million in 2022, then tumbled by 31.46% to $231.0 million in 2023, then fell by 12.67% to $201.7 million in 2024, then dropped by 7.25% to $187.1 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Long-Term Investments are $187.1 million (Q4 2025), $180.7 million (Q3 2025), and $175.5 million (Q2 2025).